Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to GT199800086ApriorityCriticalpatent/GT199800086A/en
Publication of GT199800086ApublicationCriticalpatent/GT199800086A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
UNA FORMULACION FARMACEUTICA QUE COMPRENDE VORICONAZOL, O UN DERIVADO FARMACEUTICAMENTE ACEPTABLE DEL MISMO Y UN DERIVADO DE CICLODEXTRINA DE FORMULA (I), EN LA QUE R1AG, R2AG Y R3AG; REPRESENTAN INDEPENDIENTEMENTE OH U O(CH2)4SO3H; SIEMPRE QUE AL MENOS UNO DE LOS R1AG, REPRESENTE O(CH2)4SO3H; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO. ES UTIL EN EL TRATAMIENTO DE INFECCIONES FUNGICAS.A PHARMACEUTICAL FORMULATION COMPRISING VORICONAZOLE, OR A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE OF THE SAME AND A CYCLODEXTRIN DERIVATIVE OF FORMULA (I), IN WHICH R1AG, R2AG AND R3AG; INDEPENDENTLY REPRESENT OH U O (CH2) 4SO3H; ALWAYS THAT AT LEAST ONE OF THE R1AG, REPRESENTATIVE OR (CH2) 4SO3H; OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME. IT IS USEFUL IN THE TREATMENT OF FUNGAL INFECTIONS.
LACTAMA COMPOUND (N) - ((S) -2-HIDROXI-3-METHYLBUTIRILE) -1- (L-ALANINIL) - (S) -1-AMINO-3-METHYL-4,5,6,7-TETRAHYDRO -2H-3-BENZAZEPIN-2-ONA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE FOR THE INHIBITION OF THE B-AMYLOID PEPTIDE RELEASE AND / OR ITS SYNTHESIS THAT USES IT AND ITS USE FOR THE FABR
DERIVATIVES OF BENCIMIDAZOL 1-ARIL-2-N, S OR O-SUBSTITUTES, ITS USE FOR THE OBTAINING OF PHARMACEUTICAL DRUGS AND PREPARATIONS CONTAINING THESE DERIVATIVES